Berkshire Hathaway
BERKSHIRE HATHAWAY INC
Key figures
Period Jan 2025 to Dec 2025ConsolidatedU.S. GAAP
RevenueDisclosed
US$371.4B
Operating marginCalculated
Could not be retrieved
Net assets to total assetsCalculated
58.7%
Company profile
Tables scroll sideways
Disclosed data
Profitability
Could not be retrieved
Growth (revenue, 4-year average)
★★★☆☆position among all companies
7.7%
Capital efficiency
★★☆☆☆position among all companies
9.3%
Revenue and profit
Performance, financial position and capital allocation
Berkshire Hathaway
Recent performance trends
Berkshire Hathaway
Cash flow trends
Consolidated indicators (8 items)
| Item | 4 years ago | 3 years ago | 2 years ago | Last year | This year |
|---|---|---|---|---|---|
| Net sales | US$276.2 billion | US$302.0 billion | US$364.5 billion | US$371.4 billion | US$371.4 billion |
| Net income | US$89.9 billion | US$-22.8 billion | US$96.2 billion | US$89.0 billion | US$67.0 billion |
| Total assets | US$959.4 billion | US$948.5 billion | US$1,070.0 billion | US$1,153.9 billion | US$1,222.2 billion |
| Shareholders' equity | US$506.2 billion | US$473.4 billion | US$561.3 billion | US$649.4 billion | US$717.4 billion |
| Net cash provided by (used in) operating activities | US$39.4 billion | US$37.4 billion | US$49.2 billion | US$30.6 billion | US$46.0 billion |
| Net cash provided by (used in) investing activities | US$29.4 billion | US$-87.6 billion | US$-32.7 billion | US$-10.3 billion | US$-44.5 billion |
| Net cash provided by (used in) financing activities | US$-28.5 billion | US$-1.7 billion | US$-14.4 billion | US$-10.4 billion | US$2.2 billion |
| Cash and cash equivalents | US$88.7 billion | US$36.4 billion | US$38.6 billion | US$48.4 billion | US$52.6 billion |
Revenue scale in the same industry
Berkshire Hathaway
Insurance carriers: 54 companies · revenue · largest first・FY Dec 2025・Consolidated・Disclosed
- 1 UnitedHealth Group US$447.6B
- 2 Berkshire HathawayThis company US$371.4B
- 3 The Cigna Group US$274.9B
- 4 Elevance Health US$199.1B
- … 50 companies
Sources and methodology
Basic indicators
| Item | Value | Consolidated / Non-consolidated | Source |
|---|---|---|---|
| Purchase of property, plant and equipment | US$20.9 billion | Consolidated | Disclosed |
| Cash and cash equivalents | US$52.6 billion | Consolidated | Disclosed |
| Net cash provided by (used in) financing activities | US$2.2 billion | Consolidated | Disclosed |
| Net cash provided by (used in) investing activities | US$-44.5 billion | Consolidated | Disclosed |
| Net cash provided by (used in) operating activities | US$46.0 billion | Consolidated | Disclosed |
| Depreciation and amortization | US$13.5 billion | Consolidated | Disclosed |
| Stockholders' equity (including non-controlling interests) | US$719.7 billion | Consolidated | Disclosed |
| Non-controlling interests | US$2.3 billion | Consolidated | Disclosed |
| Net assets | US$717.4 billion | Consolidated | Disclosed |
| Net sales | US$371.4 billion | Consolidated | Disclosed |
| Net income | US$67.0 billion | Consolidated | Disclosed |
| Total assets | US$1,222.2 billion | Consolidated | Disclosed |
| Operating margin | Cannot be calculated | Not applicable | Not calculated (no operating income in this year's 10-K) |
| Net assets to total assets | 58.7% | Consolidated | Calculated |
| Net margin | 18.0% | Consolidated | Calculated |
| Return on equity | 9.3% | Consolidated | Calculated |